-
Kenya prepares to build a fifth submarine cable to connect Djibouti
Time of Update: 2023-01-02
Kenya and Djibouti, in partnership with the private sector, plan to invest 6 billion shillings to lay Kenya's fifth submarine cable, DARE.
Kenya and Djibouti, in partnership with the private sector, plan to invest 6 billion shillings to lay Kenya's fifth submarine cable, DARE.
-
Aging Cell Du Yifeng's team reveals a new mechanism of long-term aerobic exercise against memory decline in Alzheimer's disease
Time of Update: 2022-12-30
, Aging Cell, 2022) Conclusion and discussion, inspiration and prospectsIn summary, this study reveals that long-term aerobic exercise can act on the BBB by promoting neuronal exosome delivery miR-532-5p through a variety of experimental methods in vitro, thereby improving its structure and function, and ultimately enhancing the trans-BBB of Aβ Clearing, improve learning and memory ability.
-
The HSS study revealed how ultraviolet light triggers immune activation and disease outbreaks in lupus patients
Time of Update: 2022-12-04
In a new study presented at the ACR Proceedings of the American College of Rheumatology 2022 Annual Meeting, researchers from the Hospital for Special Surgery (HSS) report that they have discovered a potential mechanism explaining this association: reduced lymphatic drainage, which contributes to the creation of photosensitivity and immune responses in lymph nodes.
-
eLife: Increased vaginal immune activity after first sexual intercourse
Time of Update: 2022-10-31
"Alison Roxby, associate professor of infectious diseases and global health at the University of Washington School of Medicine and co-senior author of the study, said: "More research on the immune changes associated with the onset of sexual activity may help us understand the reasons for the increased risk of STIs in young women.
-
Chai Jijie and collaborators in the School of Life Sciences first revealed the bifunctional disease resistance mechanism of plant immune receptor proteins
Time of Update: 2022-10-01
In a long battle against pathogenic bacteria, plants have evolved a fine, complex, multi-layered immune system to protect themselves from aggression. Pattern Recognition Receptors (PRRs) localized to
-
Application of centralized power fire emergency lighting and evacuation indication system in primary school projects
Time of Update: 2022-10-01
Based on the "Technical Standard for Fire Emergency Lighting and Evacuation Indication System" (GB51309-2018), this paper takes the emergency lighting system used by the two primary schools as an example to explain the scope of application, system composition and construction points of the two centralized power supply systems.
-
Gao Jinming/Fu Yangxin/Li Bo and others found that metabolizing "waste" lactic acid can enhance anti-tumor immunity
Time of Update: 2022-09-21
Thesis link: open reprint welcome to forward to the circle of friends and WeChat group SourceChina Biotechnology Reticulated Lactic Acid (Lactate), has always been considered to be a metabolic waste produced by carbohydrate fermentation or anaerobic glycolysis of skeletal muscle during exercise.
-
ESMO directly hit the melanoma innovation therapy has gains and losses, and the oncolytic virus is the perfect assist
Time of Update: 2022-09-21
BEMPEG combined with the PD-1 inhibitor navuliyumab (NIVO) in patients with advanced melanoma showed clinical activity and controllable safety in the Phase 1/2 PIVOT-02 study.
BEMPEG combined with the PD-1 inhibitor navuliyumab (NIVO) in patients with advanced melanoma showed clinical activity and controllable safety in the Phase 1/2 PIVOT-02 study.
-
The speed of generic drugs "going overseas" has intensified, and the news of foreign approval of products continues
Time of Update: 2022-08-15
After this approval, according to the US CGT (competitive generic therapy) Act, Hengrui Medicine Iodixanol injection will obtain a 180-day market exclusivity period, and is expected to become a product of Hengrui Medicine with overseas sales of over US$100 million At the end of May this year, Hengrui Medicine's iodixanol was approved in the ANDA (generic drug listing) application in the United States.
-
Empowering county-level experts to authoritatively explain the "National Grassroots Diabetes Prevention and Management Guidelines (2022
Time of Update: 2022-06-02
Pan Jiemin from Shanghai Sixth People's Hospital were the speakers, respectively interpreting the main points of the new version of the "Guide", the research on the improvement of blood sugar fluctuations in the treatment of type 2 diabetes with traditional Chinese medicine, the health management of diabetes at the grassroots level, and the treatment drugs for diabetes, etc.
-
How viruses turn immune cells into cancer
Time of Update: 2021-12-27
A research team led by Imperial College London and Kumamoto University in Japan used single-cell analysis to reveal how the virus over-activated T cells (key immune cells in our blood), causing them Cancerous .
-
Sub-Journal of The Lancet: Is immunotherapy administered during the day or at night
Time of Update: 2021-12-05
Recently, The Lancet Oncology published a study that the time for melanoma patients to receive immunotherapy has a certain impact on the survival of patients, and PD-1 inhibitors may be best injected before 4:30 in the afternoon [3] .
-
Immunity when macrophages release steam
Time of Update: 2021-11-11
Professor Gerhard Krönke explained that by affecting the cellular metabolism of macrophages and deliberately uncoupling their mitochondria, it is possible to accelerate and support the resolution of the inflammatory process in the long term .
-
Professor Han Weidong interviewed to quell CRS, tocilizumab escorted CAR-T precision treatment
Time of Update: 2021-10-01
CRS: CAR-T cells specifically recognize tumor-associated antigen targets after reinfusion into the patient's body, and the recognition and binding triggers the activation of CAR-T cells, and induces a large number of inflammatory cytokines such as interleukin 1 (IL-1) and IL-2 , IL-6 and tumor necrosis factor (TNF) release .
-
Hengrui Medicine's SHR-1701 injection and bevacizumab injection were approved for clinical trials
Time of Update: 2021-09-12
SHR-1701 injection has carried out a number of solid tumor clinical trials in China and a phase I clinical trial in Australia .
